Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT07682662 Clinical Landscape Report 2026
9 min read
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT07682662 Clinical Landscape Report 2026
11 September 2026
NCT07682662 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
CRT-402 in Myositis: NCT07778446 Clinical Landscape Report 2026
9 min read
CRT-402 in Myositis: NCT07778446 Clinical Landscape Report 2026
11 September 2026
NCT07778446 clinical landscape for Myositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07812636 Clinical Landscape Report 2026
9 min read
Tirzepatide in Endometrioid intraepithelial neoplasia: NCT07812636 Clinical Landscape Report 2026
11 September 2026
NCT07812636 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Carboplatin in Triple Negative Breast Cancer: NCT07786428 Clinical Landscape Report 2026
9 min read
Carboplatin in Triple Negative Breast Cancer: NCT07786428 Clinical Landscape Report 2026
11 September 2026
NCT07786428 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
MRT-6160 in Arthritis, Psoriatic: NCT07801495 Clinical Landscape Report 2026
9 min read
MRT-6160 in Arthritis, Psoriatic: NCT07801495 Clinical Landscape Report 2026
11 September 2026
NCT07801495 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Casdatifan in Renal Cell Carcinoma: NCT07748988 Clinical Landscape Report 2026
9 min read
Casdatifan in Renal Cell Carcinoma: NCT07748988 Clinical Landscape Report 2026
11 September 2026
NCT07748988 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SOT-106 in Metastatic osteosarcoma: NCT07801222 Clinical Landscape Report 2026
9 min read
SOT-106 in Metastatic osteosarcoma: NCT07801222 Clinical Landscape Report 2026
11 September 2026
NCT07801222 clinical landscape for Metastatic osteosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tezepelumab in Severe asthma: NCT07363642 Clinical Landscape Report 2026
9 min read
Tezepelumab in Severe asthma: NCT07363642 Clinical Landscape Report 2026
11 September 2026
NCT07363642 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
SKB-571 in Pancreatic Cancer: NCT07814066 Clinical Landscape Report 2026
9 min read
SKB-571 in Pancreatic Cancer: NCT07814066 Clinical Landscape Report 2026
11 September 2026
NCT07814066 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
JANX-007 in Metastatic castration-resistant prostate cancer: NCT07813637 Clinical Landscape Report 2026
9 min read
JANX-007 in Metastatic castration-resistant prostate cancer: NCT07813637 Clinical Landscape Report 2026
11 September 2026
NCT07813637 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
HRS-1597 in Obesity: NCT07808918 Clinical Landscape Report 2026
9 min read
HRS-1597 in Obesity: NCT07808918 Clinical Landscape Report 2026
11 September 2026
NCT07808918 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Bevacizumab biosimilar (Bio-Thera Solutions) in Platinum-Resistant Primary Peritoneal Carcinoma: NCT07811271 Clinical Landscape Report 2026
9 min read
Bevacizumab biosimilar (Bio-Thera Solutions) in Platinum-Resistant Primary Peritoneal Carcinoma: NCT07811271 Clinical Landscape Report 2026
11 September 2026
NCT07811271 clinical landscape for Platinum-Resistant Primary Peritoneal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →